Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Hip lateralisation in children with bilateral spastic cerebral palsy treated with botulinum toxin type A: a 2-year follow-up.

Jung NH, Heinen F, Westhoff B, Doederlein L, Reissig A, Berweck S, Linder-Lucht M, Schandelmaier S, Mall V; German Abo study group..

Neuropediatrics. 2011 Feb;42(1):18-23. doi: 10.1055/s-0031-1275344. Epub 2011 Apr 15.

PMID:
21500143
2.

Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.

Williams SA, Reid S, Elliott C, Shipman P, Valentine J.

Dev Med Child Neurol. 2013 Sep;55(9):813-20. doi: 10.1111/dmcn.12200. Epub 2013 Jun 22.

3.

Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.

Lundy CT, Doherty GM, Fairhurst CB.

Dev Med Child Neurol. 2009 Sep;51(9):705-10. doi: 10.1111/j.1469-8749.2009.03315.x. Epub 2009 Apr 21.

4.

Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial.

Graham HK, Boyd R, Carlin JB, Dobson F, Lowe K, Nattrass G, Thomason P, Wolfe R, Reddihough D.

J Bone Joint Surg Am. 2008 Jan;90(1):23-33. doi: 10.2106/JBJS.F.01416.

PMID:
18171954
5.

Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. Review.

PMID:
19142573
6.

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003469. doi: 10.1002/14651858.CD003469.pub4. Review.

PMID:
20091546
7.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048
8.

No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.

Alhusaini AA, Crosbie J, Shepherd RB, Dean CM, Scheinberg A.

Dev Med Child Neurol. 2011 Jun;53(6):553-8. doi: 10.1111/j.1469-8749.2011.03930.x.

9.

The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy.

Willoughby K, Ang SG, Thomason P, Graham HK.

Dev Med Child Neurol. 2012 Aug;54(8):743-7. doi: 10.1111/j.1469-8749.2012.04340.x. Epub 2012 Jun 12.

10.

[Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].

Deleplanque B, Lagueny A, Flurin V, Arnaud C, Pedespan JM, Fontan D, Pontallier JR.

Rev Chir Orthop Reparatrice Appar Mot. 2002 May;88(3):279-85. French.

PMID:
12037484
11.

Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.

Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.

Disabil Rehabil. 2013 Apr;35(7):596-605. doi: 10.3109/09638288.2012.711898. Epub 2012 Aug 28.

12.

Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.

Lin YC, Lin IL, Chou TF, Lee HM.

J Neuroeng Rehabil. 2016 Mar 12;13:25. doi: 10.1186/s12984-016-0135-8.

13.

The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial.

Boyd RN, Dobson F, Parrott J, Love S, Oates J, Larson A, Burchall G, Chondros P, Carlin J, Nattrass G, Graham HK.

Eur J Neurol. 2001 Nov;8 Suppl 5:109-19.

PMID:
11851739
14.

Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A.

Pidcock FS, Fish DE, Johnson-Greene D, Borras I, McGready J, Silberstein CE.

Arch Phys Med Rehabil. 2005 Mar;86(3):431-5.

PMID:
15759224
15.

Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.

Linder M, Schindler G, Michaelis U, Stein S, Kirschner J, Mall V, Berweck S, Korinthenberg R, Heinen F.

Eur J Neurol. 2001 Nov;8 Suppl 5:120-6.

PMID:
11851740
16.

Comparison of botulinum toxin type A injection and soft-tissue surgery to treat hip subluxation in children with cerebral palsy.

Yang EJ, Rha DW, Kim HW, Park ES.

Arch Phys Med Rehabil. 2008 Nov;89(11):2108-13. doi: 10.1016/j.apmr.2008.04.019.

PMID:
18996239
17.

Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.

Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ.

Am J Phys Med Rehabil. 2003 Apr;82(4):284-9.

PMID:
12649654
18.

Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN.

J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12.

PMID:
24630348
19.

Sonography-guided injection of botulinum toxin A in children with cerebral palsy.

Berweck S, Feldkamp A, Francke A, Nehles J, Schwerin A, Heinen F.

Neuropediatrics. 2002 Aug;33(4):221-3. Review.

PMID:
12368994
20.

Long-term effects of botulinum toxin A in children with cerebral palsy.

Tedroff K, Granath F, Forssberg H, Haglund-Akerlind Y.

Dev Med Child Neurol. 2009 Feb;51(2):120-7. doi: 10.1111/j.1469-8749.2008.03189.x.

Supplemental Content

Support Center